EnerSys to Buy Ultralife in $320 Million All-Cash Deal
ULBI sits 30% above its 52-week low of $4.9.
Summary
EnerSys entered into a definitive agreement to acquire Ultralife for $16.00 per share in cash, a $320 million all-cash transaction that represents a 166% premium to Ultralife's unaffected closing share price on Oct 26 and dwarfs Ultralife's roughly $106 million market value, putting a hard floor under the stock. The deal values Ultralife at roughly $320 million, including the assumption of net debt, and EnerSys will fund it with cash on hand through a subsidiary tender offer for a majority of shares, expecting $15M-$20M in annual synergies and closing in Q1 2027. The transaction expands advanced, differentiated battery technologies with U.S.-based manufacturing and accelerates EnerSys' growth in mission-critical defense applications, adding scale in munitions, soldier power, drones, counter-drone systems and autonomous systems. Both boards approved the deal unanimously, and closing requires tender of at least a majority of outstanding shares plus regulatory approvals; stockholders holding about 40.3% of shares have signed tender and support agreements, either party owes a $10.3 million termination fee, and the outside date is April 27, 2027. EnerSys sees the deal adding to adjusted diluted earnings per share within about 18 months after closing, and once it closes Ultralife stock will no longer trade on any public market. The transaction follows Ultralife's Q2 2026 filing on August 7, which showed a sharp operational rebound with record backlog and margin gains but also flagged an unremediated material weakness in internal controls. For holders, the key question is now deal terms and closing conditions rather than the operating turnaround, and the all-cash structure means the payoff is tied to the transaction clearing, not to Ultralife's standalone execution.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — Ultralife stockholders holding about 40.3% of shares signed tender and support agreements; either party owes a $10.3 million termination fee, and the outside date is April 27, 2027.
· Benzinga — EnerSys will fund the $16-per-share deal with cash on hand via a subsidiary tender offer for a majority of shares, expecting $15M-$20M annual synergies and closing in Q1 2027.
- Deal Value — The deal values Ultralife at roughly $320 million, including the assumption of net debt.
- Earnings Accretion — EnerSys sees the deal adding to adjusted diluted earnings per share within about 18 months after closing.
- Closing Conditions — Closing requires tender of at least a majority of outstanding shares plus regulatory approvals.
- Delisting — Once the deal closes, Ultralife stock will no longer trade on any public market.
- Board Approval — Both boards approved the deal unanimously.
- Strategic Fit — The purchase adds scale in munitions, soldier power, drones, counter-drone systems and autonomous systems.
- Executive Comments — EnerSys CEO Shawn O'Connell called the acquisition "a compelling strategic fit"; Ultralife CEO Michael Manna said the combination delivers "substantial and certain cash value to Ultralife shareholders."
All 8 details
- Deal values Ultralife at roughly $320 million, including the assumption of net debt.
- EnerSys sees the deal adding to adjusted diluted earnings per share within about 18 months after closing.
- Once the deal closes, Ultralife stock will no longer trade on any public market.
- Both boards approved the deal unanimously.
- Closing requires tender of at least a majority of outstanding shares plus regulatory approvals
- EnerSys CEO Shawn O'Connell called the acquisition "a compelling strategic fit"
- Ultralife CEO Michael Manna said the combination delivers "substantial and certain cash value to Ultralife shareholders"
- Purchase adds scale in munitions, soldier power, drones, counter-drone systems and autonomous systems.
At the time of this announcement, ULBI was trading at $6.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $106M. The 52-week trading range was $4.90 to $8.25. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.